Eli Lilly And Company (LLY): Today's Featured Health Care Winner
Eli Lilly and Company (LLY) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.4%. By the end of trading, Eli Lilly and Company rose 23 cents (0.6%) to $41.80 on average volume. Throughout the day, 5.1 million shares of Eli Lilly and Company exchanged hands as compared to its average daily volume of 6.3 million shares. The stock ranged in a price between $41.50-$41.99 after having opened the day at $41.59 as compared to the previous trading day's close of $41.57. Other companies within the Health Care sector that increased today were: Tengion (TNGN), up 30.4%, Escalon Medical Corporation (ESMC), up 24.9%, PhotoMedex (PHMD), up 18.9%, and Biostar Pharmaceuticals (BSPM), up 15.7%. Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. Eli Lilly and Company has a market cap of $48.32 billion and is part of the drugs industry. The company has a P/E ratio of 10.8, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 2.3% year to date as of the close of trading on Wednesday. Currently there are three analysts that rate Eli Lilly and Company a buy, two analysts rate it a sell, and 12 rate it a hold. TheStreet Ratings rates Eli Lilly and Company as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full Eli Lilly and Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about LLY
-
Cramer's 6 Stocks in 60 Seconds: GME LLY RBCN AXP HRL CLH (Update 1)
05:10PM 06/14/13
-
Analysts' Actions: ALGN EXC JCI LLY MRK
08:12AM 05/28/13
-
It's Pipeline That Matters Most
04:30AM 05/04/13
-
Cramer: Big Pharma Has Lost Its Way
11:49AM 05/03/13
-
Cramer's 'Mad Money' Recap: Good Earnings, Bad Market
08:09PM 05/01/13
-
Cramer's 'Mad Money' Recap: A Lemming Market
07:52PM 04/24/13
-
Cramer's 6 Stocks in 60 Seconds: JNPR EW HSY PNRA RLGY LLY (Update 1)
05:16PM 04/24/13
Latest from TheStreet Wire
-
Sprint Nextel Stock Falls On Unusually High Volume (S)
12:43PM 06/19/13
-
NVIDIA Stock Hits New 52-Week High (NVDA)
11:40AM 06/19/13
-
3 Buy-Rated Dividend Stocks: SLF, RDS.B, CXW
11:30AM 06/19/13
-
5 Buy-Rated Dividend Stocks: MAA, MBT, PSE, SNH, RDS.A
11:30AM 06/19/13
-
4 Buy-Rated Dividend Stocks: BKCC, GBDC, NMFC, NRP
11:30AM 06/19/13
-
4 Hold-Rated Dividend Stocks: ATAX, BBEP, NTE, DOM
11:30AM 06/19/13
-
3 Buy-Rated Dividend Stocks: DFT, LMT, RAI
11:30AM 06/19/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
